- Biotech investors should be wary of the inevitable rotation of the industry. The iShares Biotech Index (IBB) is down 3.5% today on slightly higher volume. Money flow as been decidedly negative over the last three weeks.
- The current price of $250 is testing support at its 10-week EMA. If it rebounds on robust volume then all is well.
- Biotech's bull run began in early 2012.
- ETFs: XBI, BIB, BBH, FBT, PBE, BIS
High flying biotech sector shows signs of rotation
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Nasdaq.com (Feb 12, 2015)
at Nasdaq.com (Jan 29, 2015)
at CNBC.com (Jan 12, 2015)
at MarketWatch.com (Jan 12, 2015)
at CNBC.com (Jan 9, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs